Performance for French Pediatric Intensive Care Units

Creation of a Composite Indicator of Clinical and Economic Performance for French Pediatric Intensive Care Units

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05491018

Acronym

QUAL-REAPED

Enrollment

13270

Registered

2022-08-08

Start date

2027-01-01

Completion date

2027-10-01

Last updated

2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severity of Illness Index

Keywords

Pediatric, intensive care, Severity of Illness, economic, scoring system

Brief summary

Introduction. The measurement of severity scores in adult and pediatric resuscitation provides a tool for evaluating the clinical performance of resuscitation services. No pediatric studies have investigated the association between current procedure and diagnostic cost indices with pediatric ICU patient severity and mortality. Objectives. The main objective of this project in real-life situations, in 14 French pediatric intensive care units, is to validate the recently available PIM3 and PRISM IV severity scores, which take into account the clinical dimension of performance in pediatric intensive care. This project is a French multicenter prospective observational research project involving 14 French pediatric intensive care units belonging to the Groupe Francophone de Réanimation et Urgences Pédiatriques (GFRUP). All patients under 18 years of age admitted to the 14 pediatric intensive care units affiliated with the GFRUP and voluntarily participating in the project will be included in the study. Expected outcomes are: Validation of PIM3 and PRISM IV scores in a French population to assess clinical performance. To develop a predictive model of mortality and a predictive model of cost in French pediatric intensive care units.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 18 Years

Healthy volunteers

Inclusion criteria

* All patients under 18 years of age admitted to the 14 pediatric intensive care units and voluntarily participating in the project will be included in the study.

Exclusion criteria

\- Children of age of reason or parents/legal guardians of children refusing participation in this project will be excluded from the study.

Design outcomes

Primary

Measure	Time frame
Survival : yes / no	At PICU discharge,through study completion, an average of 2 years

Secondary

Measure	Time frame
cost of PICU stay	At PICU discharge,through study completion, an average of 2 years

Contacts

CONTACTStéphane Leteurtre, MD,PhD

stephane.leteurtre@chru-lille.fr03 20 44 68 84

PRINCIPAL_INVESTIGATORStéphane Leteurtre, MD,PhD

University Hospital, Lille

Outcome results